What did Abbott pay for Cardiovascular Systems, Inc.?

Abbott acquired Cardiovascular Systems, Inc. for $850.0M in 2023, equivalent to 3.30x revenue. Target revenue was approximately $256.0M.

What does Cardiovascular Systems, Inc. do?

Cardiovascular Systems, Inc. is a medical devices business.

What multiple did Abbott pay for Cardiovascular Systems, Inc.?

3.30x revenue, based on disclosed deal value of $850.0M and disclosed financials.

M&A TRANSACTION · 2023

Cardiovascular Systems, Inc. acquired by Abbott

$850.0M· 3.30x revenue

Target

Cardiovascular Systems, Inc.

Acquirer

Abbott

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$256.0M

EBITDA

—

Deal Value

$850.0M

EV/EBITDA

—

Context

This $850.0M acquisition of Cardiovascular Systems, Inc. by Abbott sits in the medical devices sub-vertical. Abbott is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Cardiovascular Systems, Inc. acquisition.

Citation: ExitValue.ai. (2023). Cardiovascular Systems, Inc. acquired by Abbott. https://exitvalue.ai/deals/cardiovascular-systems-inc-acquired-by-abbott-fairness-opi